BioLife Solutions Market Cap 2006-2019 | BLFS
BioLife Solutions market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. BioLife Solutions market cap as of December 11, 2019 is $0.32B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.320B | $0.020B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $148.956B | 20.58 |
| Abbott Laboratories (ABT) | United States | $148.320B | 27.06 |
| Stryker (SYK) | United States | $74.970B | 25.21 |
| Boston Scientific (BSX) | United States | $60.924B | 28.76 |
| Baxter (BAX) | United States | $41.636B | 25.25 |
| Essilor Luxottica (ESLOY) | France | $33.188B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.178B | 18.93 |
| Terumo (TRUMY) | Japan | $26.560B | 33.15 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.341B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.099B | 38.73 |
| ResMed (RMD) | United States | $21.470B | 39.61 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.169B | 531.35 |
| Bio-Rad Laboratories (BIO) | United States | $10.705B | 51.38 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.421B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.212B | 13.45 |
| Hill-Rom Holdings (HRC) | United States | $7.115B | 20.98 |
| Haemonetics (HAE) | United States | $5.955B | 40.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| NuVasive (NUVA) | United States | $3.869B | 30.46 |
| ICU Medical (ICUI) | United States | $3.704B | 24.15 |
| Neogen (NEOG) | United States | $3.501B | 58.58 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.090B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.969B | 0.00 |
| Quidel (QDEL) | United States | $2.961B | 28.10 |
| Aurora Cannabis (ACB) | Canada | $2.855B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.471B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.404B | 54.25 |
| Cardiovascular Systems (CSII) | United States | $1.562B | 0.00 |
| InMode (INMD) | Israel | $1.365B | 0.00 |
| Aphria (APHA) | $1.278B | 0.00 | |
| AtriCure (ATRC) | United States | $1.204B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.154B | 23.11 |
| Phibro Animal Health (PAHC) | United States | $0.983B | 18.41 |
| NanoString Technologies (NSTG) | United States | $0.937B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.924B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.794B | 19.84 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.777B | 29.75 |
| Quanterix (QTRX) | United States | $0.701B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.686B | 38.53 |
| PetIQ (PETQ) | United States | $0.685B | 16.70 |
| Omeros (OMER) | United States | $0.654B | 0.00 |
| HEXO (HEXO) | $0.589B | 0.00 | |
| Surmodics (SRDX) | United States | $0.555B | 57.72 |
| Cerus (CERS) | United States | $0.543B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.487B | 29.22 |
| Owens & Minor (OMI) | United States | $0.484B | 17.91 |
| MacroGenics (MGNX) | United States | $0.481B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.420B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.400B | 13.77 |
| Utah Medical Products (UTMD) | United States | $0.384B | 27.83 |
| Zynex (ZYXI) | United States | $0.313B | 35.44 |
| Bovie Medical (APYX) | United States | $0.271B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.261B | 0.00 |
| United Health Products (UEEC) | United States | $0.246B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.239B | 25.20 |
| Repro-Med Systems (KRMD) | United States | $0.235B | 0.00 |
| Vapotherm (VAPO) | United States | $0.226B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.178B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.172B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.158B | 796.00 |
| Chimerix (CMRX) | United States | $0.155B | 0.00 |
| Female Health (VERU) | United States | $0.151B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.127B | 8.98 |
| Cytosorbents (CTSO) | United States | $0.122B | 0.00 |
| United-Guardian (UG) | United States | $0.090B | 22.77 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.073B | 0.00 |
| Nephros (NEPH) | United States | $0.065B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.061B | 0.00 |
| Surface Oncology (SURF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.014B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
